Peng Jiang et al.35 reported that MG53 mediates K48-linked ubiquitin-proteasome degradation of AMPKα2 in skeletal muscle of type 2 diabetes and obesity models, suppressing AMPK signaling pathway activation. The gene discussed is PRKAA2; the disease is type 2 diabetes mellitus.